BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 175 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $481,679 | -26.9% | 34,879 | +16.9% | 0.00% | – |
Q2 2023 | $659,221 | +1.4% | 29,829 | -0.2% | 0.00% | – |
Q1 2023 | $650,195 | +2.4% | 29,894 | -14.3% | 0.00% | – |
Q4 2022 | $634,780 | -19.9% | 34,878 | +0.1% | 0.00% | – |
Q3 2022 | $792,000 | +75.6% | 34,829 | +6.7% | 0.00% | – |
Q2 2022 | $451,000 | -17.1% | 32,640 | +36.5% | 0.00% | – |
Q1 2022 | $544,000 | -58.4% | 23,919 | -31.8% | 0.00% | – |
Q4 2021 | $1,307,000 | +14.9% | 35,069 | +30.5% | 0.00% | – |
Q3 2021 | $1,138,000 | +12.1% | 26,880 | +17.9% | 0.00% | – |
Q2 2021 | $1,015,000 | +59.3% | 22,800 | +28.8% | 0.00% | – |
Q1 2021 | $637,000 | -21.4% | 17,700 | -12.8% | 0.00% | – |
Q4 2020 | $810,000 | +21.1% | 20,300 | -12.1% | 0.00% | – |
Q3 2020 | $669,000 | +77.0% | 23,100 | 0.0% | 0.00% | – |
Q2 2020 | $378,000 | +145.5% | 23,100 | +42.6% | 0.00% | – |
Q1 2020 | $154,000 | -8.3% | 16,200 | +55.8% | 0.00% | – |
Q4 2019 | $168,000 | -2.9% | 10,400 | 0.0% | 0.00% | – |
Q3 2019 | $173,000 | – | 10,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |